FDA relaxes cardiovascular trial requirements for diabetes drugs

被引:0
|
作者
Asher Mullard [ ]
机构
关键词
D O I
10.1038/d41573-020-00071-7
中图分类号
学科分类号
摘要
引用
收藏
页码:298 / 298
相关论文
共 50 条
  • [21] Novel Diabetes Drugs and the Cardiovascular Specialist
    Sattar, Naveed
    Petrie, Mark C.
    Zinman, Bernard
    Januzzi, James L., Jr.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (21) : 2646 - 2656
  • [22] JAMA relaxes requirements on industry sponsored studies
    McCarthy, Michael
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [23] Living building challenge group relaxes requirements
    Post, Nadine M.
    ENR (Engineering News-Record), 2019, 282 (11):
  • [24] DRUGS TREATING EPILEPSY, FELINE DIABETES RECEIVE FDA APPROVAL
    Lederhouse, Coco
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2023, 261 (11): : 1617 - 1617
  • [25] Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs
    Scott, Pamela E.
    Unger, Ellis F.
    Jenkins, Marjorie R.
    Southworth, Mary Ross
    McDowell, Tzu-Yun
    Geller, Ruth J.
    Elahi, Merina
    Temple, Robert J.
    Woodcock, Janet
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (18) : 1960 - 1969
  • [26] DIABETES DRUGS - CLINICAL-TRIAL
    PROUT, TE
    KNATTERUD, GL
    MEINERT, CG
    SCIENCE, 1979, 204 (4391) : 362 - 363
  • [27] Cardiovascular impact of drugs used in the treatment of diabetes
    Triggle, Chris R.
    Ding, Hong
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2014, 5 (06) : 245 - 268
  • [28] Cardiovascular effects of anti-diabetes drugs
    Younk, Lisa M.
    Lamos, Elizabeth M.
    Davis, Stephen N.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (09) : 1239 - 1257
  • [29] Diabetes drugs pass cardiovascular risk check
    Opar, Alisa
    NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (05) : 343 - U8
  • [30] Treating diabetes: Cardiovascular benefits of antidiabetes drugs
    Harmel, AP
    AMERICAN JOURNAL OF MANAGED CARE, 2002, 8 (08): : S219 - S228